Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Nihon Kohden Corporation ( (JP:6849) ) is now available.
Nihon Kohden has completed a share repurchase program authorized by its board in December 2025, acquiring 1,364,900 common shares on the Tokyo Stock Exchange between March 1 and March 24, 2026 for about 2.1 billion yen via market purchases under a discretionary transaction agreement. Cumulatively under this authorization, the company bought back 3,135,900 shares for roughly 5.0 billion yen, a move that tightens its share float and may enhance capital efficiency and shareholder value through a reduced number of shares outstanding.
The buyback reflects Nihon Kohden’s active capital allocation strategy at a time when many Japanese listed companies are under pressure to improve returns and optimize balance sheets. By nearly exhausting the authorized 5 billion yen ceiling, the company signals confidence in its financial position and future prospects, while potentially improving earnings per share and supporting its market valuation in the competitive medical device sector.
The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1583.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation is a Japan-based medical device manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The company specializes in diagnostic and patient monitoring equipment and related healthcare technologies, serving hospitals and medical institutions in Japan and global markets.
Average Trading Volume: 679,578
Technical Sentiment Signal: Sell
Current Market Cap: Yen251.7B
For detailed information about 6849 stock, go to TipRanks’ Stock Analysis page.